Therapeutic vaccines for gastrointestinal cancers

Osama E. Rahma, Samir N. Khleif

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Despite progress in the management of gastrointestinal malignancies, these diseases remain devastating maladies. Conventional treatment with chemotherapy and radiation is still only partially effective and highly toxic. In the era of increasing knowledge of the molecular biology of tumors and the interaction between the tumor and immune system, the development of targeted agents, including cancer vaccines, has emerged as a promising modality. In this paper, we discuss the principals of vaccine development, and we review most of the published trials on gastrointestinal cancer vaccines that have been conducted over the last decade. Many antigens and various treatment approaches have already been tested in colon, pancreatic, and other cancers. Some of these approaches have already shown some clinical benefit. In this paper, we discuss these different strategies and some of the future directions for targeting gastrointestinal malignancies with vaccines.

Original languageEnglish (US)
JournalGastroenterology and Hepatology
Volume7
Issue number8
StatePublished - Aug 1 2011

Fingerprint

Gastrointestinal Neoplasms
Vaccines
Cancer Vaccines
Neoplasms
Gastrointestinal Diseases
Poisons
Therapeutics
Pancreatic Neoplasms
Molecular Biology
Immune System
Colon
Radiation
Antigens
Drug Therapy

Keywords

  • Cancer vaccine
  • Gastrointestinal
  • Malignancies
  • Review
  • Trials

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Therapeutic vaccines for gastrointestinal cancers. / Rahma, Osama E.; Khleif, Samir N.

In: Gastroenterology and Hepatology, Vol. 7, No. 8, 01.08.2011.

Research output: Contribution to journalArticle

Rahma, Osama E. ; Khleif, Samir N. / Therapeutic vaccines for gastrointestinal cancers. In: Gastroenterology and Hepatology. 2011 ; Vol. 7, No. 8.
@article{576bccd0c8ee42ca8b5be4eeb04cab85,
title = "Therapeutic vaccines for gastrointestinal cancers",
abstract = "Despite progress in the management of gastrointestinal malignancies, these diseases remain devastating maladies. Conventional treatment with chemotherapy and radiation is still only partially effective and highly toxic. In the era of increasing knowledge of the molecular biology of tumors and the interaction between the tumor and immune system, the development of targeted agents, including cancer vaccines, has emerged as a promising modality. In this paper, we discuss the principals of vaccine development, and we review most of the published trials on gastrointestinal cancer vaccines that have been conducted over the last decade. Many antigens and various treatment approaches have already been tested in colon, pancreatic, and other cancers. Some of these approaches have already shown some clinical benefit. In this paper, we discuss these different strategies and some of the future directions for targeting gastrointestinal malignancies with vaccines.",
keywords = "Cancer vaccine, Gastrointestinal, Malignancies, Review, Trials",
author = "Rahma, {Osama E.} and Khleif, {Samir N.}",
year = "2011",
month = "8",
day = "1",
language = "English (US)",
volume = "7",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "8",

}

TY - JOUR

T1 - Therapeutic vaccines for gastrointestinal cancers

AU - Rahma, Osama E.

AU - Khleif, Samir N.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Despite progress in the management of gastrointestinal malignancies, these diseases remain devastating maladies. Conventional treatment with chemotherapy and radiation is still only partially effective and highly toxic. In the era of increasing knowledge of the molecular biology of tumors and the interaction between the tumor and immune system, the development of targeted agents, including cancer vaccines, has emerged as a promising modality. In this paper, we discuss the principals of vaccine development, and we review most of the published trials on gastrointestinal cancer vaccines that have been conducted over the last decade. Many antigens and various treatment approaches have already been tested in colon, pancreatic, and other cancers. Some of these approaches have already shown some clinical benefit. In this paper, we discuss these different strategies and some of the future directions for targeting gastrointestinal malignancies with vaccines.

AB - Despite progress in the management of gastrointestinal malignancies, these diseases remain devastating maladies. Conventional treatment with chemotherapy and radiation is still only partially effective and highly toxic. In the era of increasing knowledge of the molecular biology of tumors and the interaction between the tumor and immune system, the development of targeted agents, including cancer vaccines, has emerged as a promising modality. In this paper, we discuss the principals of vaccine development, and we review most of the published trials on gastrointestinal cancer vaccines that have been conducted over the last decade. Many antigens and various treatment approaches have already been tested in colon, pancreatic, and other cancers. Some of these approaches have already shown some clinical benefit. In this paper, we discuss these different strategies and some of the future directions for targeting gastrointestinal malignancies with vaccines.

KW - Cancer vaccine

KW - Gastrointestinal

KW - Malignancies

KW - Review

KW - Trials

UR - http://www.scopus.com/inward/record.url?scp=80052614730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052614730&partnerID=8YFLogxK

M3 - Article

VL - 7

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 8

ER -